Post by GSK

We’re excited to be in Stockholm at #EHA2026! We’re connecting with the global haematology community and sharing our latest progress toward transforming what’s possible in care for people living with blood diseases and cancers, including myelofibrosis. From anaemia to fatigue, the daily challenges faced by those living with myelofibrosis are persistent, and so is our determination to extending and improving their lives. Learn more about the perspectives of the myelofibrosis community: https://gsk.to/4gdOnTR